Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts

Archives of Facial Plastic Surgery

Volumn 7, Issue 1, 2005, Pages 27-31

  Pollard, Jeffrey D ^a   Quan, Susan ^a   Kang, Thomas ^a   Koch, R James ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLYCYL HISTIDYL LYSINE; GLYCYL-HISTIDYL-LYSINE; GROWTH PROMOTOR; OLIGOPEPTIDE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; FIBROBLAST; HUMAN; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE; WOUND HEALING;

CELL DIVISION; CELL LINE; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; OLIGOPEPTIDES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 17144407587     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.7.1.27     Document Type: Article

References (33)

1. Brew EC, Mitchell MB, Harken AH. Fibroblast growth factors in operative wound healing. J Am Coll Surg. 1995;180:499-504.
2. Schweigerer L. Basic fibroblast growth factor as a wound healing hormone. Trends Pharmacol Sci. 1988;9:427-428.
3. Gospodarowicz D. Biological activities of fibroblast growth factors. Ann N Y Acad Sci. 1991;638:1-8.
4. Raghow R, Postlethwaite AE, Keski-Oji J, Moses HL, Kang AH. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest. 1987;79:1285-1288.
5. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg. 1996; 98:827-833.
6. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor beta. Biochim Biophys Acta. 1990;1032:79-87.
7. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol. 1987;105:1039-1045.
8. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 1990;63:245-257.
9. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol. 1992;119:1017-1021.
10. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors. 1993;8:1-9.
11. Amento EP, DeGuzman L, Lee WP, Xu Y, McFatridge LL, Beck LS. The systemic administration of TGF-beta 1 accelerates wound healing. J Cell Biochem. 1991; 15(suppl F):191.
12. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
13. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor isoforms. Mol Biol Cell. 1993;4:1317-1326.
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family. Mol Endocrinol. 1991;5:1806-1814.
15. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol. 1999;237:1-30.
16. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132.
17. Yang R, Thomas GR, Bunting S, et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 1996; 27:838-844.
18. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024-1028.
19. Moore MJ. The effect of radiation on connective tissue. Otolaryngol Clin North Am. 1984;17:389-396.
20. Teknos TN, Myers LL. Surgical reconstruction after chemotherapy or radiation: problems and solutions. Hematol Oncol Clin North Am. 1999;13:679-687.
21. Buffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther. 1995;330:345-360.
22. 2+. Life Sci. 1992;51:1049-1056.
23. Pickart L. Copper peptides for tissue regeneration. Spec Chem Mag. October 2002: 29-31.
24. 2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67:2257-2265.
25. 2+. FEBS Lett. 1988;238:343-346.
26. 2+ in rat experimental wounds. J Clin Invest. 1993;92:2368-2376.
27. Massey P, Patt LM, D'Aoust JC. The effect of glycyl-L-histidyl-L-lysine copper chelate on the healing of diabetic ulcers: a pilot study. Wounds. 1998;4:21-28.
28. Fish FS, Katz I, Hien NT, Briden ME, Johnson JA, Patt LM. Evaluation of glycyl-L-histidyl-L-lysine copper complex in acute wound healing: effects in post Mohs' surgery wounds. Wounds. 1991;3:171-177.
29. McCormack MC, Nowak KC, Koch RJ. The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. Arch Facial Plast Surg. 2001;3:28-32.
30. 2 laser energy on keloid and normal dermal fibroblast secretion of growth factors: a serum-free study. Plast Reconstr Surg. 2000;105:2039-2048.
31. Hong R, Lum J, Koch RJ. Growth of keloid-producing fibroblasts in commercially available serum-free media. Otolaryngol Head Neck Surg. 1999;121:469-473.
32. Koch RJ, Goode RL, Simpson GT. Serum-free keloid fibroblast cell culture: an in vitro model for the study of aberrant wound healing. Plast Reconstr Surg. 1997; 99:1094-1098.
33. Glantz SA. Primer of Biostatistics for Windows 95 and 3x: The Program Version 4.0. New York, NY: McGraw-Hill Co; 1996.